Published June 3, 2026 | Version v1
Journal article Open

Combined Endoscopic Sinus Surgery and Rhinosinus Surgery for Obstructive Nasal Syndromes

  • 1. M.B.Ch.B., F.I.C.M.S. \ (ENT), Specialist in Otolaryngology, Iraqi Ministry of Health, Al-Karkh Health Directorate, Abu-Ghraib General Hospital, Baghdad, Iraq.
  • 2. M.B.Ch.B., F.I.B.M.S. \ (ENT), Specialist in Otolaryngology, Iraqi Ministry of Health, Al-Karkh Health Directorate, Abu-Ghraib General Hospital, Baghdad, Iraq.
  • 3. M.B.Ch.B., F.I.B.M.S. \ (ENT), Specialist in Otolaryngology, Iraqi Ministry of Health, Al-Karkh Health Directorate, Pediatric Central Teaching Hospital, Baghdad, Iraq.

Description

Background: The clinical symptoms and treatment outcomes of chronic sinusitis are influenced by environmental factors, limited access to health care services, and it is a significant health burden in Iraq. The main goal of this research was to assess the efficacy of FESS and assistive procedures in the nose. A prospective observational study was performed from January 2025 to January 2026, in two specialized ENT centers in Iraq, where 134 patients with drug-resistant chronic sinusitis were included. Our primary outcome measures included the SNOT-22 score, the nasal obstruction/ facial pain/ smell (visual symmetry) scores, and the NOSE score.

·        Significant improvement was observed in all outcome measures after 12 months, the SNOT-22 from 52.4±18.7 to 18.8±10.6

·        The NOSE score from 72.8±16.4 to 20.2±11.6

·        The peak inspiratory nasal airflow increased from 78.4±28.6 to 132.8±31.2 L/min

·        Surgical success, overall, did not change after 12 months (82.1%).

In summary, in Iraqi people with treatment-resistant chronic sinusitis, high BMI, and EDSS are independent predictors of decreased likelihood of success.

Files

SJM-181- 2026-1-8.pdf

Files (988.0 kB)

Name Size Download all
md5:d2df3920a184660d8618c58c795668a4
988.0 kB Preview Download